At Lonza's facility in Bend (OR), our core capabilities include bioavailability enhancement, respiratory delivery, and multiparticulates. Our comprehensive offering extends beyond these core capabilities, encompassing material-sparing formulation development that continues seamlessly through the commercialization phase. Our early-phase clinical manufacturing facility provides agile, quick-to-clinic capabilities. The co-location of our expert formulators with our commercial manufacturing facility will ensure the success of your molecule.

The presentation will:

  • Explore strategies how to overcome your bioavailability enhancement challenges
  • Discuss the respiratory delivery expertise of the Bend Inhalation Group
  • Demonstrate how our experts can help you to formulate multiparticulates that align with your project goals


By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center